Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke

Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke

Background: To discover novel metabolic biomarkers of ischemic stroke (IS), we carried out a two-stage metabolomic profiling of IS patients and healthy controls using untargeted and targeted metabolomic approaches.Methods: We applied untargeted liquid chromatography-mass spectrometry (LC-MS) to dete...

Full description

Bibliographic Details
Main Authors: Fang Yu, Xi Li, Xianjing Feng, Minping Wei, Yunfang Luo, Tingting Zhao, Bo Xiao, Jian Xia
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
ischemic stroke
metabolomics
biomarkers
phenylacetylglutamine
microbiota
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.798765/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.798765/full

Similar Items